Heidelberg Pharma (Germany) Performance
| HPHA Stock | EUR 2.42 0.00 0.00% |
The company retains a Market Volatility (i.e., Beta) of 0.45, which attests to possible diversification benefits within a given portfolio. As returns on the market increase, Heidelberg Pharma's returns are expected to increase less than the market. However, during the bear market, the loss of holding Heidelberg Pharma is expected to be smaller as well. At this point, Heidelberg Pharma has a negative expected return of -0.018%. Please make sure to check out Heidelberg Pharma's information ratio, maximum drawdown, and the relationship between the variance and jensen alpha , to decide if Heidelberg Pharma performance from the past will be repeated at some point in the near future.
Risk-Adjusted Performance
0 of 100
Weak | Strong |
Very Weak
Over the last 90 days Heidelberg Pharma AG has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of comparatively stable basic indicators, Heidelberg Pharma is not utilizing all of its potentials. The newest stock price uproar, may contribute to short-horizon losses for the private investors. ...more
| Begin Period Cash Flow | 5 M | |
| Free Cash Flow | -28 M |
Heidelberg |
Heidelberg Pharma Relative Risk vs. Return Landscape
If you would invest 249.00 in Heidelberg Pharma AG on October 8, 2024 and sell it today you would lose (7.00) from holding Heidelberg Pharma AG or give up 2.81% of portfolio value over 90 days. Heidelberg Pharma AG is generating negative expected returns and assumes 2.4806% volatility on return distribution over the 90 days horizon. Simply put, 22% of stocks are less volatile than Heidelberg, and 99% of all equity instruments are likely to generate higher returns than the company over the next 90 trading days. Expected Return |
| Risk |
Heidelberg Pharma Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for Heidelberg Pharma's investment risk. Standard deviation is the most common way to measure market volatility of stocks, such as Heidelberg Pharma AG, and traders can use it to determine the average amount a Heidelberg Pharma's price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = -0.0072
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns | HPHA |
Estimated Market Risk
| 2.48 actual daily | 22 78% of assets are more volatile |
Expected Return
| -0.02 actual daily | 0 Most of other assets have higher returns |
Risk-Adjusted Return
| -0.01 actual daily | 0 Most of other assets perform better |
Based on monthly moving average Heidelberg Pharma is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Heidelberg Pharma by adding Heidelberg Pharma to a well-diversified portfolio.
Heidelberg Pharma Fundamentals Growth
Heidelberg Stock prices reflect investors' perceptions of the future prospects and financial health of Heidelberg Pharma, and Heidelberg Pharma fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Heidelberg Stock performance.
| Current Valuation | 194.72 M | |||
| Price To Book | 25.46 X | |||
| Price To Sales | 12.57 X | |||
| Revenue | 1.75 M | |||
| EBITDA | (24.84 M) | |||
| Cash Flow From Operations | (26.61 M) | |||
| Total Asset | 21.73 M | |||
About Heidelberg Pharma Performance
Assessing Heidelberg Pharma's fundamental ratios provides investors with valuable insights into Heidelberg Pharma's financial health and overall profitability. This information is crucial for making informed investment decisions. A high ROA would indicate that the Heidelberg Pharma is effectively leveraging its assets and equity to generate significant profits, making it an appealing investment. Conversely, low Return on Assets could signal underlying management issues in assets and equity, indicating a necessity for operational refinements. Please also refer to our technical analysis and fundamental analysis pages.
Things to note about Heidelberg Pharma performance evaluation
Checking the ongoing alerts about Heidelberg Pharma for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for Heidelberg Pharma help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| Heidelberg Pharma generated a negative expected return over the last 90 days | |
| Heidelberg Pharma has a very high chance of going through financial distress in the upcoming years | |
| The company reported the revenue of 1.75 M. Net Loss for the year was (26.14 M) with profit before overhead, payroll, taxes, and interest of 0. | |
| Heidelberg Pharma generates negative cash flow from operations |
- Analyzing Heidelberg Pharma's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Heidelberg Pharma's stock is overvalued or undervalued compared to its peers.
- Examining Heidelberg Pharma's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating Heidelberg Pharma's management team can have a significant impact on its success or failure. Reviewing the track record and experience of Heidelberg Pharma's management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of Heidelberg Pharma's stock. These opinions can provide insight into Heidelberg Pharma's potential for growth and whether the stock is currently undervalued or overvalued.
Additional Tools for Heidelberg Stock Analysis
When running Heidelberg Pharma's price analysis, check to measure Heidelberg Pharma's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Heidelberg Pharma is operating at the current time. Most of Heidelberg Pharma's value examination focuses on studying past and present price action to predict the probability of Heidelberg Pharma's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Heidelberg Pharma's price. Additionally, you may evaluate how the addition of Heidelberg Pharma to your portfolios can decrease your overall portfolio volatility.